Display Settings:

Format

Send to:

Choose Destination
    Exp Clin Psychopharmacol. 2002 Aug;10(3):276-85.

    Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder.

    Source

    Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Carolina 29401, USA. bradyk@musc.edu

    Abstract

    Studies investigating carbamazepine (CBZ) in the treatment of cocaine dependence have been inconsistent. In this study, cocaine-dependent individuals with (n = 57) and without (n = 82) affective disorder were compared in a 12-week, double-blind, placebo-controlled trial. Urine drug screens (UDS) and self-report of drug use were collected weekly. Affective symptoms were measured monthly. Subjects receiving CBZ attended more medication sessions (p = .03). The CBZ-treated affective group had a trend toward fewer cocaine-positive UDS (p = .08) and a significantly longer time to first cocaine use (p = .06). CBZ treatment did not have any impact on cocaine use in individuals without affective disorders.

    PMID:
    12233988
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for American Psychological Association

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk